Target WP4 - Ricapps

The network

research programme

02

WP 4. To develop tools for the early detection of non-communicable diseases in primary care, and develop screening strategies and interventions for the secondary prevention of such diseases.

Coordinator

Rafel Ramos

CARDIOCAT Research Group (Girona)

RD21/0016/0001

rramos.girona.ics@gencat.cat

Participating Groups

Cardiocat. IP:

Rafel Ramos (RD21/0001/0001)

BIPS. IP:

Alvaro Sanchez (RD21/0001/0003)

AQUAS. IP:

Mireia Espallargues (RD21/0001/0007)

GRAP-caIB. IP:

Alfonso Leiva (RD21/0001/0009)

GIAPCyL. IP:

Luis García (RD21/0001/0010)

SAMSERAP. IP:

Juan Bellon (RD21/0001/0012)

Canary Islands. IP:

Lilisbeth Perestelo (RD21/0001/0013)

Kronikgune - 1. IP:

Susana García (RD21/0001/0017)

IMIM. IP:

María Sala (RD21/0001/0020)

Galicia. IP:

Francisco Gude (RD21/0001/0022)

Madrid-AP. IP:

César Minué (RD21/0001/0026)

F. Avedis Donabedian. IP:

Carola Orrego (RD21/0001/0028)

GRenSSAP. IP:

Anna Berenguera (RD21/0001/0029)

Research lines

Line 1 To design early detection and risk prediction tools for common and/or relevant diseases in secondary prevention, with the inclusive and longitudinal approach envisaged in primary care. Early detection tools, at the onset of diseases, would improve the optimisation of preventive measures and, therefore, delay the progression of diseases. Risk prediction tools in secondary prevention would help to identify patients at greater risk of their disease worsening, which would make it possible to intervene in time to slow the progression of the illness.

Task 1.To design tools for the early detection of common and/or relevant diseases.

Task 2.To design tools for predicting risk in the secondary prevention of common and/or relevant diseases.

Line 2 To design, analyse and evaluate the effectiveness and cost-effectiveness of screening and early detection strategies for common and/or relevant diseases in primary care. Identifying more effective and cost-effective screening strategies would enable the detection of diseases in the early stages, with a direct impact on improving disease control, progression and prognosis.

Task 1.To evaluate the effectiveness and cost-effectiveness of screening and early detection strategies for common and/or relevant diseases.

Line 3 To carry out comparative studies to evaluate the effectiveness and cost-effectiveness of pharmacological and non-pharmacological interventions for the secondary prevention of common and/or relevant diseases at different stages of life. The impact of these studies is expected to reduce the incidence of new events or the worsening of existing diseases.

Task 1.To carry out studies to evaluate the effectiveness and cost-effectiveness of non-pharmacological interventions for the secondary prevention of common and/or relevant diseases.

Task 2.To carry out studies to evaluate the effectiveness and cost-effectiveness of pharmacological interventions for the secondary prevention of common and/or relevant diseases.

Line 4 To design, develop and evaluate community actions and health promotion programmes. To develop tools for the implementation and evaluation of strategies for health promotion and community participation.

Task 1.To design, develop and evaluate community actions in different population groups (adults, women, children and adolescents).

Task 2.To develop and evaluate community and emotional wellbeing strategies in different population groups.

Task 3.To promote active and healthy ageing, in accordance with the European Scaling-Up Strategy in Active and Healthy Ageing.

Task 4.To develop reports, community action guides and strategic plans for health promotion and community participation.